ArticleFEBS open bio2025
An optimized protocol to detect high-throughput DNA methylation from custom targeted sequences on 96 samples simultaneously.
Article in FEBS open bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Genome methylation represents an important source of regulation of gene expression. To date, custom molecular tools for studying targeted regions of the genome are restricted to several megabases. We developed a protocol to epigenotype differentially methylated CpGs in specific regions of the genome. The protocol describes a targeted methylation library preparation upstream short read sequencing with an Illumina instrument. The protocol includes the New England Biolabs Next Enzymatic Methyl-seq Library Preparation workflow combined with the Twist Bioscience Targeted Methylation Sequencing workflow. The protocol is divided into eight steps: fragmentation, library preparation, enzymatic conversion, indexing, pooling, hybridization, capture, and amplification. Main advantages are (a) a lower amount of DNA (100 and 50 ng) than other technologies, (b) the limitation of DNA degradation using enzymatic conversion instead of chemical bisulfite, (c) the pooling of samples into 8-plex reducing handling time, and (d) the significant reduction of the panel quantity divided by 20 for saving experimental costs. This protocol was carried out on 96 samples simultaneously in a standard molecular biology laboratory, and the multiplexing can be run up to 384 samples for methylation experiments. We developed a high-throughput epigenotyping method as an alternative of methylation arrays. This approach can be adapted to any interesting regions using a custom panel for agronomic species and model organisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.